covid drug

Zenara Pharma gets CDSCO panel nod to manufacture Covid drug

The approval by the Central Drugs Standard Control Organisation (CDSCO) has been granted under the emergency authorisation route, Zenara Pharma said in a statement.

published on : 28th July 2022

Scientists identify potential drug candidate against COVID-19 

The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle.

published on : 15th August 2020